Coverage of highly active antiretroviral therapy among postpartum women in Malawi

International Journal of STD and AIDS

Volumn 22, Issue 7, 2011, Pages 368-372

  Kumwenda, J ^a   Matchere, F ^b   Mataya, R ^c   Chen, S ^d   Mipando, L ^b   Li, Q ^d   Kumwenda, N I ^d   Taha, T E ^d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Access; Antiretroviral therapy; Coverage; HAART; HIV; Malawi; Mother to child transmission; Postpartum women; Treatment

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALAWI; MOTHER CHILD RELATION; PRIORITY JOURNAL; PUERPERIUM; SINGLE DRUG DOSE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG UTILIZATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALAWI; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; POSTPARTUM PERIOD; PREGNANCY;

EID: 79959976311     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010359     Document Type: Article

References (20)

1. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004;18:887-95
2. Jordan R, Gold L, Cummins C, Hyde C. Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ 2002;324:757
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60
4. World Health Organization. The HIV and Infant Feeding Revised Principles and Recommendations, Rapid Advice, November 2009. See http://whqlibdoc.who.int/publications/2009/9789241598873_eng.pdf (last accessed 15 January 2010)
5. World Health Organization. HIV and Infant Feeding. Update based on the technical consultation held on behalf of the Inter-agency Task Team (IATT) on prevention of HIV infections in pregnant women, mothers and their infants. Geneva: WHO, 2006. See: http://whqlibdoc.who.int/publications/2007/9789241595964_eng.pdf (last accessed 15 January 2009)
6. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-16
7. Kuhn L, Aldrovandi G, Sinkala M, et al. High uptake of exclusive breastfeeding and reduced post-natal HIV transmission: prospective results from the Zambia exclusive breastfeeding study [Abstract]. Abs TUAX103. Fourth IAS Conference on HIV Pathogenesis, Treatment and Prevention., incorporating the 19th ASHM Conference. Sydney, Australia. See www.ias2007.org/pag/Abstracts.aspx?SID1/452&AID1/41784 (last accessed 15 April 2011)
8. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Eng J Med 2008;359:119-29
9. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis 2009;200:1490-7
10. Mofenson LM, Taha TE, LI Q, et al. Infant extended antiretroviral (ARV) prophylaxis is effective in preventing postnatal mother-to-child HIV transmission (MTCT) at all maternal CD4 counts [Abstract]. Fifth IAS conference on HIV Pathogenesis, Treatment and Prevention, 19-22 July 2009
11. Peltier CA, Ndayisaba GF, Lepage P, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 2009;23:2415-23
12. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 2008;371:752-9
13. World Health Organization. Towards Universal Access: Scaling up Priority HIV/ AIDS Interventions in the Health Sector. Progress report, 2008. Geneva: World Health Organization, 2008
14. Malawi HIV and AIDS Monitoring and Evaluation Report. See http://data.unaids.org/pub/Report/2008/malawi_2008_country_progress_report_en.pdf (last accessed 16 December 2009)
15. UNICEF Malawi. Report: The Situation of Women and Children. See http://www.unicef.org/malawi/children.html (last accessed 20 December 2010)
16. Malawi Ministry of Health. Antiretroviral Therapy in the Public and Private Sectors in Malawi: Results up to 30 December 2007. Lilongwe: Ministry of Health, Malawi, 2007
17. Muula AS, Chipeta J, Siziya S, Rudatsikira E, Mataya RH, Kataika E. Human resources requirements for highly active antiretroviral therapy scale up in Malawi. BMC Health Serv Res 2007;7:208
18. Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res 1974;9:208-20
19. Posse M, Meheus F, van Asten H, van der Ven A. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Heath 2008;13:904-13
20. Tsai AC, Chopra M, Pronyk PM, Martinson NA. Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings. AIDS Care 2009;21:59-63